Pharmaceutical Executive August 15, 2024
To safeguard patient access to life-saving medications, pharma companies must prioritize building robust resilience strategies that encompass IT systems, inventory management, risk mitigation, and regulatory compliance.
COVID-19 brought in enormous attention to Pharma resilience as the world faced a global pandemic and prepared for an unprecedented vaccine rollout across the world. But the importance of this topic is not limited to the pandemic. Climate changes, geopolitical tensions/wars, cyber-attacks, reputational damages, financial risks, currency risks, natural disasters, solar flares, and many unforeseen issues can cause massive supply chain network disruptions and impact the availability of life-saving drugs and critical therapies. Many similar disparate incidents caused disruptions in the global pharmaceutical supply chain. In addition to this constant challenge of counterfeiting, regulatory...
Today's Sponsors
Today's Sponsor